Humankind Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Sell |
1,349
-435
| -24% | -$169K | 0.13% | 86 |
|
|
2025
Q1 | $776K | Buy |
1,784
+89
| +5% | +$38.7K | 0.2% | 67 |
|
|
2024
Q4 | $625K | Buy |
1,695
+505
| +42% | +$186K | 0.16% | 70 |
|
|
2024
Q3 | $619K | Buy |
1,190
+66
| +6% | +$34.3K | 0.22% | 67 |
|
|
2024
Q2 | $609K | Sell |
1,124
-190
| -14% | -$103K | 0.16% | 70 |
|
|
2024
Q1 | $681K | Sell |
1,314
-20
| -1% | -$10.4K | 0.18% | 64 |
|
|
2023
Q4 | $629K | Sell |
1,334
-10
| -0.7% | -$4.72K | 0.19% | 62 |
|
|
2023
Q3 | $585K | Sell |
1,344
-31
| -2% | -$13.5K | 0.24% | 55 |
|
|
2023
Q2 | $611K | Buy |
1,375
+496
| +56% | +$220K | 0.24% | 56 |
|
|
2023
Q1 | $404K | Buy |
879
+4
| +0.5% | +$1.84K | 0.17% | 75 |
|
|
2022
Q4 | $449K | Buy |
875
+18
| +2% | +$9.23K | 0.19% | 71 |
|
|
2022
Q3 | $389K | Buy |
857
+126
| +17% | +$57.2K | 0.19% | 69 |
|
|
2022
Q2 | $353K | Buy |
731
+122
| +20% | +$58.9K | 0.17% | 72 |
|
|
2022
Q1 | $299K | Sell |
609
-23
| -4% | -$11.3K | 0.12% | 89 |
|
|
2021
Q4 | $293K | Buy |
632
+6
| +1% | +$2.78K | 0.37% | 80 |
|
|
2021
Q3 | $233K | Buy |
626
+21
| +3% | +$7.82K | 0.36% | 86 |
|
|
2021
Q2 | $231K | Buy |
+605
| New | +$231K | 0.41% | 75 |
|